Literature DB >> 12204364

Evaluation of restriction fragment length polymorphism analysis of 16S rDNA as a tool for genomovar characterisation within the Burkholderia cepacia complex.

Karen Vermis1, Christoph Vandekerckhove, Hans J Nelis, Peter A R Vandamme.   

Abstract

A total of 154 Burkholderia cepacia complex strains, isolated from cystic fibrosis and non-cystic fibrosis patients and the environment, representing all nine genomovars and a putative tenth, were analysed by 16S rDNA-restriction fragment length polymorphism using the restriction enzymes AluI, CfoI and DdeI. Examining this diverse strain collection resulted in very diverse restriction patterns. Only B. cepacia genomovar VI could be identified unambiguously. The same restriction patterns were observed for B. cepacia genomovars I and III and approximately half of the Burkholderia ambifaria, B. anthina and B. pyrrocinia strains. Burkholderia vietnamiensis and B. ubonensis, a putative tenth B. cepacia complex genomovar, shared identical restriction profiles. The majority of Burkholderia multivorans and B. stabilis isolates generated a unique restriction pattern, but two strains of each showed divergent restriction profiles which were also observed in other genomovars.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204364     DOI: 10.1111/j.1574-6968.2002.tb11316.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  2 in total

1.  Differentiation of species combined into the Burkholderia cepacia complex and related taxa on the basis of their fatty acid patterns.

Authors:  Eva Krejcí; Reiner M Kroppenstedt
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

2.  Polyphasic characterisation of Burkholderia cepaciacomplex species isolated from children with cystic fibrosis.

Authors:  Fernando José Vicenzi; Marcelo Pillonetto; Helena Aguilar Peres Homem de Mello de Souza; Jussara Kasuko Palmeiro; Carlos Antônio Riedi; Nelson Augusto Rosario-Filho; Libera Maria Dalla-Costa
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-01       Impact factor: 2.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.